Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121

Sean A. Hudson; Kirsty J. McLean; S. Surade; Yong-Qing Yang; David Leys; Alessio Ciulli; Andrew W. Munro; C. Abell

doi:10.1002/anie.201202544

Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121

Sean A. Hudson, Kirsty J. McLean, S. Surade, Yong-Qing Yang, David Leys, Alessio Ciulli, Andrew W. Munro, C. Abell

Research output: Contribution to journal › Article › peer-review

68 Citations (Scopus)

Abstract

Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging.

Original language	English
Pages (from-to)	9311-9316
Number of pages	6
Journal	Angewandte Chemie International Edition
Volume	51
Issue number	37
DOIs	https://doi.org/10.1002/anie.201202544
Publication status	Published - 10 Sept 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/anie.201202544

Cite this

@article{40496d88433a421ea5057d8e42908359,

title = "Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121",

abstract = "Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging. ",

author = "Hudson, {Sean A.} and McLean, {Kirsty J.} and S. Surade and Yong-Qing Yang and David Leys and Alessio Ciulli and Munro, {Andrew W.} and C. Abell",

note = "MEDLINE{\textregistered} is the source for the MeSH terms of this document.",

year = "2012",

month = sep,

day = "10",

doi = "10.1002/anie.201202544",

language = "English",

volume = "51",

pages = "9311--9316",

journal = "Angewandte Chemie International Edition",

issn = "1433-7851",

publisher = "Wiley",

number = "37",

}

TY - JOUR

T1 - Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121

AU - Hudson, Sean A.

AU - McLean, Kirsty J.

AU - Surade, S.

AU - Yang, Yong-Qing

AU - Leys, David

AU - Ciulli, Alessio

AU - Munro, Andrew W.

AU - Abell, C.

N1 - MEDLINE® is the source for the MeSH terms of this document.

PY - 2012/9/10

Y1 - 2012/9/10

N2 - Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging.

AB - Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging.

UR - http://www.scopus.com/inward/record.url?scp=84865835782&partnerID=8YFLogxK

U2 - 10.1002/anie.201202544

DO - 10.1002/anie.201202544

M3 - Article

C2 - 22890978

AN - SCOPUS:84865835782

SN - 1433-7851

VL - 51

SP - 9311

EP - 9316

JO - Angewandte Chemie International Edition

JF - Angewandte Chemie International Edition

IS - 37

ER -

Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this